Alterations in some blood coagulation parameters in naturally occurring cases of canine babesiosis

Acta Veterinaria Hungarica

Volumn 57, Issue 2, 2009, Pages 295-304

  Rafaj, Renata Barić ^a   Matijatko, Vesna ^a   Kiš, Ivana ^a   Kučer, Nada ^a   Živičnjak, Tatjana ^a   Lemo, Niksa ^a   Žvorc, Zdravko ^a   Brkljačić, Mirna ^a   Mrljak, Vladimir ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Babesia canis; Coagulation; Dog; Haemostasis

Indexed keywords

ANTIPROTOZOAL AGENT; ANTITHROMBIN III; DRUG DERIVATIVE; IMIDOCARB; IMIDOCARB DIPROPIONATE; THROMBIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; BABESIOSIS; BLOOD; BLOOD CLOTTING DISORDER; DOG; DOG DISEASE; FEMALE; MALE; METABOLISM; PARTIAL THROMBOPLASTIN TIME;

ANIMALS; ANTIPROTOZOAL AGENTS; ANTITHROMBIN III; BABESIOSIS; BLOOD COAGULATION DISORDERS; DOG DISEASES; DOGS; FEMALE; IMIDOCARB; MALE; PARTIAL THROMBOPLASTIN TIME; THROMBIN;

ANIMALIA; BABESIA; BABESIA CANIS; BABESIA CANIS CANIS; CANIS FAMILIARIS;

EID: 68249135338     PISSN: 02366290     EISSN: 15882705     Source Type: Journal    
DOI: 10.1556/AVet.57.2009.2.10     Document Type: Article

References (38)

1. Bateman, S. W., Mathews, K. A., Abrams-Ogg, A. C., Lumsden, J. H., Johnstone, I. B., Hillers, T. K. and Foster, R. A. (1999): Diagnosis of disseminated intravascular coagulation in dogs admitted to an intensive care unit. J. Am. Vet. Med. Assoc. 215, 798-804.
2. Bick, R. L. (1996): Disseminated intravascular coagulation: Objective clinical and laboratory diagnosis, treatment, and assessment of therapeutic response. Sem. Thromb. Haemost. 22, 69-88.
3. Boozer, A. L. and MacIntire, D. K. (2003): Canine babesiosis. Vet. Clin. N. Amer. Small Anim. Pract. 33, 885-904.
4. Caccio, S. M., Antunovic, B., Moretti, A., Mangili, V., Marinculic, A., Baric Rafaj, R., Slemenda S. S. and Pieniazek, N. J. (2002): Molecular characterisation of Babesia canis canis and Babesia canis vogeli from naturally infected European dogs. Vet. Parasitol. 106, 285-292.
5. D'Angelo, A., Della Valle, P., Giudici, D. and Viganò D'Angelo, S. (2004): Protein C and coagulation in sepsis. Minerva Anestesiol. 70, 339-350.
6. Esmon, C. T. (2004): Crosstalk between inflammation and thrombosis. Maturitas 47, 305-314.
7. Esmon, C. T. (2005): The interaction between inflammation and coagulation. Brit. J. Haematol. 131, 417-430.
8. Esmon, C. T., Fukudome, K., Mather, T., Bode, W., Regan, L. M., Stearns-Kurosawa, D. J. and Kurosawa, S. (1999): Inflammation, sepsis, and coagulation. Haematologica 84, 254-259.
9. Furlanello, T., Fiorio, F., Caldin, M., Lubas, G. and Solano-Gallego, L. (2005): Clinicopathological findings in naturally occurring cases of babesiosis caused by large form Babesia from dogs of northeastern Italy. Vet. Parasitol. 134, 77-85.
10. Gentile, N. T., Vaidyula, V. R., Kanamalla, U., DeAngelis, M., Gaughan, J. and Rao, A. K. (2007): Factor VIIa and tissue factor procoagulant activity in diabetes mellitus after acute ischemic stroke: impact of hyperglycemia. Thromb. Haemost. 98, 1007-1013.
11. Goodger, B. V., Redebramanis, K. and Wright, I. G. (1987): Procoagulant activity of Babesia bovis-infected erythrocytes. J. Parasitol. 73, 1052-1060.
12. Humphries, J. E. (1995): Thrombophilia and complex acquired deficiencies of antithrombin, protein C, and protein S. Semin. Hematol. 32, 8-16.
13. Jacobson, L. S. (2006): The South African form of severe and complicated canine babesiosis: clinical advances 1994-2004. Vet. Parasitol. 138, 126-139.
14. Jacobson, L. S. and Clark, I. A. (1994): Supportive treatment of canine babesiosis. J. S. Afr. Vet. Assoc. 66, 95-105.
15. Korte, W., Clarke, S. and Lefkowitz, J. B. (2000): Short activated partial thromboplastin times are related to increased thrombin generation and an increased risk for thromboembolism. Am. J. Clin. Pathol. 113, 123-127.
16. Kume, K., Yamasaki, M., Tashiro, M., Yoshikawa, I. and Otsuki, M. (2007): Activations of coagulation and fibrinolysis secondary to bowel inflammation in patients with ulcerative colitis. Intern. Med. 46, 1323-1329.
17. Mammen, E. F. (2000): Disseminated intravascular coagulation (DIC). Clin. Lab. Sci. 13, 239-245.
18. Mastrorilli, C., Dondi, F., Agnoli, C., Turba, M. E., Vezzali, E. and Gentilini, F. (2007): Clinicopathologic features and outcome predictors of Leptospira interrogans australis serogroup infection in dogs: A retrospective study of 20 cases (2001-2004). J. Vet. Int. Med. 21, 3-10.
19. Máthé, Á., Vörös, K., Papp, L. and Reiczigel, J. (2006): Clinical manifestations of canine babesiosis in Hungary (63 cases). Acta Vet. Hung. 54, 367-385.
20. Matijatko, V., Mrljak, V., Kiš, I., Kucer, N., Foršek, J., Živicnjak, T., Romic, Ž., Šimec, Z. and Ceron, J. J. (2007): Evidence of an acute phase response in dogs naturally infected with Babesia canis. Vet. Parasitol. 144, 242-250.
21. Matyszko, J. and Tymcio, J. (2008): Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with essential arterial hypertension. Pol. Arch. Med. Wewn. 118, 36-41.
22. Moore, D. J. and Williams, M. C. (1979): Disseminated intravascular coagulation: A complication of Babesia canis infection in the dog. J. S. Afr. Vet. Assoc. 50, 265-275.
23. Mrljak, V., Baric Rafaj, R., Sušić, V., Matijatko, V., Kucer, N. and Kiš, I. (2005): Antithrombin III in healthy dogs and in dogs suffering from babesiosis. Vet. Arhiv 75, 477-486.
24. Nel, M., Lobetti, R. G., Keller, N. and Thompson, P. N. (2004): Prognostic value of blood lactate, blood glucose, and hematocrit in canine babesiosis. J. Vet. Intern. Med. 18, 471-476.
25. Oglsbee, M J., Diehl, K., Crawford, R., Kearns, R and Krakowka, S. (1999): Whole body hyperthermia effects upon canine immune and hemostatic functions. Vet. Immunol. Immunopathol. 69, 185-199.
26. Ravanat, C., Freund, M., Dol, F., Cadroy, Y., Roussi, J., Incardona, F., Maffrand, J. P., Boneu, B., Drouet, L. and Legrand, C. (1995): Cross-reactivity of human molecular markers for detection of prethrombotic states in various animal species. Blood Coagul. Fibrinolysis. 6, 446-455.
27. Ruiz de Gopegui, R., Penalba, B., Goicoa, A., Espada, Y., Fidalgo, L. E. and Espino, L. (2007): Clinico-pathological findings and coagulation disorders in 45 cases of canine babesiosis in Spain. Vet. J. 174, 129-132.
28. Schetters, T. P. M. (2005): Vaccination against canine babesiosis. Trends Parasitol. 21, 179-184.
29. Schetters, T. P. M., Moubri, K., Precigout, E., Kleuskens, J., Scholters, N. C. and Gorenflot, A. (1997): Different Babesia canis isolates, different diseases. Parasitology 115, 485-493.
30. Tarnow, I., Falk, T., Tidholm, A., Martinussen, T., Jensen, A. L., Olsen, H., Pedersen, H. D. and Kristensen, A. T. (2007): Hemostatic biomarkers in dogs with chronic congestive heart failure. J. Vet. Int. Med. 21, 451-457.
31. ten Boekel, E., Böck, M., Vrielink, G. J., Liem, R., Hemdriks, H. and de Kieviet, W. (2007): Detection of shortened activated partial thromboplastin times: an evaluation of different commercial reagents. Thromb. Res. 121, 361-367.
32. ten Boekel, E., de Kieviet, W. and Bartels, P. C. (2003): Subjects with a shortened activated partial thromboplastin time show increased in-hospital mortality associated with elevated D-dimer, C-reactive protein and glucose levels. Scand. J. Clin. Lab. Invest. 63, 441-448.
33. Uilenberg, G., Franssen, F. F., Perié, N. M. and Soanjer, A. A. (1989): Three groups of Babesia canis distinguished and a proposal for nomenclature. Vet. Quart. 11, 33-40.
34. Ulutas, B., Bayramli, G., Ulutas, P. A. and Karagenc, T. (2005): Serum concentration of some acute phase proteins in naturally occurring canine babesiosis: a preliminary study. Vet. Clin. Path. 34, 144-147.
35. Warren, B. L., Eid, A., Singer, P., Pillay, S. S., Carl, P., Novak, I., Chalupa, P., Atherstone, A., Pénzes, I., Kübler, A., Knaub, A., Keinecke, H-O., Heinrichs, H., Schindel, F., Juers, M., Bone, R. C. and Opal, S. M. (2001): High-dose antithrombin III in severe sepsis. A randomized controlled trial. J. Am. Med. Assoc. 286, 1869-1878.
36. Wiinberg, B., Jensen, A. L., Johansson, P. I., Rozanski, E., Traholm, M. and Kristensen, A. T. (2008): Thromboelastographic evaluation of hemostatic function in dogs with disseminated intravascular coagulation. J. Vet. Int. Med. 22, 357-365.
37. Williamson, L. H. (1991): Antithrombin III: A natural anticoagulant. Comp. Cont Educ. Vet. 13, 100-107.
38. Zygner, W., Gójska, O., Rapacka, G., Jaros, D. and Wedrychowitz, H. (2006): Hematological changes during the course of canine babesiosis caused by large Babesia in domestic dogs in Warsaw (Poland). Vet. Parasitol. 145, 141-151.